27 Jan 2021  • 

Hatch-Waxman 101 for the Emerging Life Science Company


Official Links

Estimated Turnout

upto 100


27 Jan 2021


Newly Listed
Claim event to edit details

This program is targeted at innovative life science companies that have filed, or will soon file, NDA or 505(b)(2) applications and are anticipating .. Read more their first Hatch-Waxman litigation. We will discuss pre-litigation considerations, including Orange Book patent listing, the interplay between patent and regulatory exclusivities, and pre-suit due diligence activities. We will also discuss Hatch-Waxman litigation mechanics, including Notice Letters, 30-month stays of FDA ANDA approval and lawsuit timing.

  • Share your Experience
  • Organizer
Logo Request a Booth


USA 12 Total Events / 4 Upcoming Events

More Events From The Organizer